About Us
Ceribell is a venture-backed medical device start-up company founded in 2014 by two faculty members at Stanford University, who were frustrated at the conventional EEG systems. To meet the clinical unmet needs, we have developed a rapid response EEG system, which makes the diagnosis of neurological patients drastically more efficient.
Mission & Vision
Ceribell is focused on making EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizure. We’ve created and validated an FDA cleared EEG system that does not require an EEG tech for a long setup or waiting for a specialist to interpret the initial results.
The system can be set up by any clinician within minutes. The Brain Stethoscope function
dramatically simplifies the interpretation of EEG results by converting brainwaves to sound
so seizure can be detected by listening. With Clarity, Ceribell offers 24/7 continuous bedside EEG monitoring and alert. Real-time monitoring enables rapid and precise treatment for patients with seizures, leading to better clinical outcomes and significant savings.
Ceribell Today
Ceribell is commercially available in the United States and we are
partnering with healthcare providers all over the country.
Today, we have over 50 employees under an accomplished leadership
team. We are constantly looking for talents to join us on this awesome
journey. Check out the career opportunities at Ceribell.
Company History
Leadership Team
Culture & Careers
Newsroom
Ceribell, Inc.
2483 Old Middlefield Way Suite 120
Mountain View, CA 94043
1.800.436.0826
